Dr. Diana Radovan

Plusultra pharma GmbH (PUP) | Mission: Contribute to Society by Providing Critical but Neglected Pharmaceuticals and Medical Devices. PUP belongs to the Nobelpharma group of companies. Nobelpharma develops drugs, medical devices, and drug-device combinations. -Regulatory Strategy including HTA process (AMNOG and NICE) -Line, vendor & cross-functional management -Medical Affairs and PV activities -Due diligence for in-licensing -Inspection readiness -Developing SOPs & best practices.

Drug Development | Regulatory Strategy | Agency Meetings | Due Diligence and Partnering | Training

Writing of clinical study reports and submission documents for biosimilars in various indications

Writer with experience in biomedical research, editing, and science communication and outreach Main skills: writing of regulatory documents (clinical study reports and submission documents), project management, international cross-disciplinary teamwork, providing training to external and internal medical writers, leading scientific and medical writing workshops Therapeutic areas: metabolism, respiratory, immunology

Supervising practical courses, offering training to BSc and MSc students

Fluorescence microscopy studies on the fibrillation of IAPP at model and cellular lipid interfaces -- from mechanism to potential strategies in the treatment of type II diabetes mellitus

BSH-induced leakage of various liposomal formulations for future cancer therapy applications

Biochemistry